Question · Q4 2025
Jarrod Giroue asked for more color on the $40 million+ in synergies already achieved from the Vital acquisition and what specific savings are expected to reach the doubled annual target of $190 million. He also inquired about Crescent's prioritization of shareholder returns in 2026, specifically between the base dividend, share repurchases, and debt reduction, following the increased buyback authorization.
Answer
CFO Brandi Kendall stated that the $40 million in synergies captured to date were largely from overhead, duplicative public company expenses, and cost of capital. She detailed that 50% of the increased synergy target is operations-related, with the remaining 50% from additional overhead, marketing, and further cost of capital reductions. COO Joey Hall elaborated on operational improvements, including increasing wells per pad for simulfrac, extending lateral lengths, and supply chain opportunities. Brandi Kendall reiterated that capital allocation priorities remain unchanged, with the balance sheet and base dividend as top priorities, focusing on deleveraging while retaining flexibility for opportunistic share repurchases.
Ask follow-up questions
Fintool can predict
CRGY's earnings beat/miss a week before the call